A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy
Public ClinicalTrials.gov record NCT05470985. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2/3, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Oral Ozanimod (RPC1063) in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy, safety, drug levels, and drug effects of ozanimod in pediatric participants with moderately to severely active Crohn's Disease.
Study identification
- NCT ID
- NCT05470985
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 5 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 2 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 21, 2023
- Primary completion
- Sep 12, 2024
- Completion
- Sep 12, 2024
- Last update posted
- Apr 21, 2025
2023 – 2024
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution - 0010 | Garden Grove | California | 92845-2032 | — |
| Local Institution - 0028 | Los Angeles | California | 90027-6062 | — |
| Local Institution - 0002 | Sacramento | California | 95817-2207 | — |
| Local Institution - 0009 | San Francisco | California | 94158 | — |
| Local Institution - 0011 | Hartford | Connecticut | 06106-3322 | — |
| Local Institution - 0044 | Orlando | Florida | 32803-1469 | — |
| Local Institution - 0037 | Orlando | Florida | 32806 | — |
| Local Institution - 0053 | Atlanta | Georgia | 30302 | — |
| Local Institution - 0059 | Indianapolis | Indiana | 46202-5109 | — |
| Local Institution - 0038 | Springfield | Massachusetts | 01199 | — |
| Local Institution - 0006 | Detroit | Michigan | 48201-2196 | — |
| Local Institution - 0003 | Rochester | Minnesota | 55905-0001 | — |
| Local Institution - 0016 | St Louis | Missouri | 63110-1002 | — |
| Local Institution - 0071 | Lebanon | New Hampshire | 03756-1000 | — |
| Local Institution - 0060 | New York | New York | 10032 | — |
| Local Institution - 0075 | Fort Worth | Texas | 76104-2710 | — |
| Local Institution - 0070 | Houston | Texas | 77030-2316 | — |
| Local Institution - 0008 | Seattle | Washington | 98105-3901 | — |
| Local Institution - 0040 | Tacoma | Washington | 98405-3720 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05470985, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 21, 2025 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05470985 live on ClinicalTrials.gov.